Previous studies suggested that the two FAS or FASL polymorphisms were not in a linkage disequilibrium and these polymorphisms had a joint effect on cancer risk [26], and the combined FAS/FASL genotypes were associated with a significantly increased risk of SCCHN. The gene discussed is FASLG; the disease is cancer.